Taken from Chapter 10 of Immune Health, Terrain & GcMAF
Every substance that enters the body begins a relationship with the internal terrain. Entry points determine how the body first encounters a molecule and how immune cells interpret it.
GcMAF, being a biologically active protein that relies on correct immune interpretation, follows the same rules. Its route of administration shapes its behaviour, the tissues that interact with it first, and the type of communication it initiates inside the terrain.
Each delivery method engages a different biological layer, and each layer contributes to immune communication in its own way.
GcMAF Cream (Dermal Route)
Dermal routes support lymphatic stability. The skin protects against external contact and hosts its own immune network. When GcMAF is applied topically, it interacts with cells within the dermal layer, contributing to surface level communication and immune interpretation within the terrain.
Spray (Mucosal Route)
Mucosal routes support early interpretation. Sprays allow GcMAF to interact with immune cells at the surface level, engaging early immune surveillance systems and supporting initial interpretation.
Oral (Mucosal Route)
The oral mucosa evaluates materials entering the mouth. When GcMAF is delivered orally, immune cells within the mucosal surface participate in its interpretation, contributing to communication pathways linked to vascular and systemic responses.
Nasal (Mucosal Route)
The nasal mucosa samples environmental input and plays a central role in early immune interpretation. Nasal delivery allows GcMAF to engage immune cells quickly, influencing how signals are recognised and processed within the terrain.
Nebulising (Pulmonary Route)
Pulmonary routes support respiratory balance. The lungs filter and oxygenate inhaled air, and alveolar macrophages respond to inhaled materials. Nebulised delivery allows deep lung tissues to participate in immune interpretation, influencing respiratory and systemic immune tone.
Subcutaneous (Sub C Route)
Subcutaneous routes support deep systemic regulation. Subcutaneous tissue contains macrophages that influence long term immune behaviour.
When GcMAF enters the subcutaneous space, it interacts with resident macrophages and lymphatic vessels, allowing immune interpreted signals to move through the body and influence multiple systems.
This route provides slow, steady communication within the terrain.
Multi Route Approach
The body does not respond uniformly to identical molecules entering through different routes. Each route provides a unique introduction to the immune landscape.
Subcutaneous delivery provides the systemic foundation, while mucosal, dermal and pulmonary routes add layers of balance and nuance, creating a broader pattern of communication throughout the terrain.
Written by Maryjayne Aria
Author of Immune Health, Terrain & GcMAF